← All stocks

Fulgent Genetics, Inc.

FLGT Net selling

CIK 0001674930 #3026 in the set updated 17 Sep 2026

Bought (120 mo)

$11.16M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$31.16M

$0.00 on a plan · $1.22M straight out of an exercise

Sold at will

$29.94M

145 of 159 sales

Net

−$20.01M

−$18.79M against sales at will

By person

13 insiders · 179 transactions

52.0×

Ming Hsieh holds 52.0 times base salary in stock. $52.02M of shares against $1.00M in salary for 2025.

Salary from the company's own proxy. The shares are what Ming Hsieh last reported holding, valued at $19.66, the price Common Stock was last bought or sold at on the open market here, on 2 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Kim Paul

CFO and Treasurer

$1.60M (1)

$18.39M (57)

−$16.80M

356,543

$7.01M

−88.1%

Xie Jian

President and COO

—

$10.77M (55)

−$10.77M

801,556

$15.76M

+30.4%

Hsieh Ming

Chief Executive Officer

$9.56M (19)

$93.48K (2)

+$9.47M

2,646,373

$52.02M

—

BOLGER JOHN C

Director

—

$1.23M (15) scheduled

−$1.23M

5,100

$100.25K

+155.0%

Gao Hanlin

Chief Scientific Officer

—

$680.30K (30)

−$680.30K

986,117

$19.38M

−92.7%

Xi Long USA, Inc. entity

10% owner

—

2,025,623

$39.82M

—

Dong Linda

Director

—

38,758

$761.84K

—

GROVES REGINA E

Director

—

28,099

$552.33K

—

Nohaile Michael

Director

—

24,578

$483.11K

—

POST LEONARD E

Director

—

8,000

$157.25K

—

Mulay James

Director

—

8,000

$157.25K

—

Fulgent Genetics, Inc. entity

Director

—

6,842

$134.49K

+140.7%

Yen Yun

Director

—

2,000

$39.31K

−100.0%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Insider

Date

Role

Action

Price

Amount

BOLGER JOHN C

31 May 2022

Director

Sold after exercise

500

$55.25

$27.63K

BOLGER JOHN C

31 May 2022

Director

Sold after exercise

313

$55.44

$17.35K

BOLGER JOHN C

31 May 2022

Director

Sold after exercise

313

$55.32

$17.32K

BOLGER JOHN C

1 Mar 2022

Director

Sold after exercise

625

$61.27

$38.29K

BOLGER JOHN C

1 Mar 2022

Director

Sold after exercise

625

$61.40

$38.38K

BOLGER JOHN C

1 Mar 2022

Director

Sold after exercise

625

$61.42

$38.39K

BOLGER JOHN C

30 Aug 2021

Director

Sold after exercise

312

$91.44

$28.53K

BOLGER JOHN C

30 Aug 2021

Director

Sold after exercise

312

$91.05

$28.41K

BOLGER JOHN C

30 Aug 2021

Director

Sold after exercise

312

$91.38

$28.51K

BOLGER JOHN C

1 Jun 2021

Director

Sold after exercise

1,876

$71.41

$133.97K

BOLGER JOHN C

9 Mar 2021

Director

Sold after exercise

3,374

$101.62

$342.88K

BOLGER JOHN C

17 Nov 2020

Director

Sold after exercise

4,269

$44.24

$188.88K

BOLGER JOHN C

17 Aug 2020

Director

Sold after exercise

3,914

$40.87

$159.97K

BOLGER JOHN C

22 May 2020

Director

Sold after exercise

8,677

$15.36

$133.29K

Show all 179 transactions →

What was left out

Form 4 filings counted 381

Amendments (4/A) skipped 5

Filings about a different issuer 0

Unreadable filings 0

Joint filings 7

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 14

Sales at will 145

Transactions with no price 0

Shares from compensation/vesting 37,252,986

Sales filed before the plan box existed 84

History held since 4 Oct 2016